Redox changes in obesity, metabolic syndrome, and diabetes

Abstract

"Life is an instantaneous encounter of circulating matter and flowing energy" (Jean Giaja, Serbian physiologist), is one of the most elegant definitions not only of life but the relationship of redox biology and metabolism. Their evolutionary liaison has created inseparable yet dynamic homeostasis in health, which, when disrupted, leads to disease. This interconnection is even more pertinent today, in an era of increasing metabolic diseases of epidemic proportions such as obesity, metabolic syndrome, and diabetes. Despite great advances in understanding the molecular mechanisms of redox and metabolic regulation, we face significant challenges in preventing, diagnosing, and treating metabolic diseases. The etiological association and temporal overlap of these syndromes present significant challenges for the discrimination of appropriate clinical biomarkers for diagnosis, treatment, and outcome prediction. These multifactorial, multiorgan metabolic syndromes with complex etiopathogenic mechanisms are accompanied by disturbed redox equilibrium in target tissues and circulation. Free radicals and reactive species are considered both a causal factor and a consequence of disease status. Thus, determining the subtypes and levels of free radicals and reactive species, oxidatively damaged biomolecules (lipids, proteins, and nucleic acids) and antioxidant defense components as well as redox-sensitive transcription factors and fluxes of redox-dependent metabolic pathways will help define existing and establish novel redox biomarkers for stratifying metabolic diseases. This review aims to discuss diverse redox/metabolic aspects in obesity, metabolic syndrome, and diabetes, with the imperative to help establish a platform for emerging and future redox-metabolic biomarkers research in precision medicine. Future research warrants detailed investigations into the status of redox biomarkers in healthy subjects and patients, including the use of emerging 'omic' profiling technologies (e.g., redox proteomes, lipidomes, metabolomes, and transcriptomes), taking into account the influence of lifestyle (diet, physical activity, sleep, work patterns) as well as circadian ~24h fluctuations in circulatory factors and metabolites.

Caffeic Acid on Metabolic Syndrome: A Review

“…The degree of reactive species production and neutralization that are tightly associated with oxidative metabolism determines the redox homeostasis of cells and their surroundings. Setting the redox states of cells is critical in both health and disorders such as MetS [ 15 ]. The question is, which antioxidant and at what aliquot would be the optimum elixir to shorten the period in combating the specific diseases.…”

The Unity of Redox and Structural Remodeling of Brown Adipose Tissue in Hypothyroidism

“…Redoxsensitive transcription factors, such as nuclear factor erythroid 2-related factor 2 (Nrf2), play a pivotal role in maintaining redox homeostasis and integrating redox and metabolic regulatory networks by regulating the expression of genes involved in the antioxidant and detoxifying response, metabolic regulation, and mitochondrial function [15][16][17][18]. As a result, there is a growing research interest in identifying redox biomarkers and redox-sensitive targets for diagnosing and treating metabolic diseases [19][20][21].…”

Role of Argwadha Nitya Virechana in Madhumeha (Diabetes Mellitus-II): A Case Study

“…Insulin impairment leads to changes in fat, and glucose metabolism leads to Diabetes. Constant high glucose level changes gradually deteriorate insulin secretion [4].…”